CORTISPORIN-TC OTIC Rx
Generic Name and Formulations:
Colistin (as sulfate) 3mg, neomycin (as sulfate) 3.3mg, hydrocortisone acetate 10mg, thonzonium bromide 0.5mg; per mL; otic susp; contains thimerosal.
Par Pharmaceutical, Inc.
Indications for CORTISPORIN-TC OTIC:
Suscepible infections of external auditory canal, mastoidectomy, fenestration cavities.
Clean ear. 5 drops (using dropper) in ear(s) 3–4 times daily; max 10 days.
Clean ear. 4 drops (using dropper) in ear(s) 3–4 times daily; max 10 days.
Cutaneous viral infections in ear (eg, herpes simplex, vaccinia, varicella zoster virus).
Perforated eardrum. Chronic otitis media. Asthma (soln). Reevaluate if no improvement in 1 week. Pregnancy (Cat.C). Nursing mothers.
Antibiotics + steroid + surfactant.
Local reactions, contact dermatitis, oto- or nephrotoxicity in prolonged use, superinfection.
Susp formerly known under the brand names Cortisporin, Oticair, Otocort, Pediotic.
TC—10mL (w. dropper); Soln—10mL (w. dropper); Susp—contact supplier
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL